| $376M | ||
| $350M | ||
| $215M | ||
| $127M | ||
| $107M | ||
| $100M |
Buys | $0 | 0 | 0 |
Sells | $701,667 | 1 | 100 |
| Laumas Sandeep | CFO and CBO | 0 | $0 | 1 | $701,667 | $-701,667 |
Instil Bio, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on devising novel therapeutic options for individuals battling cancer. A cornerstone of their research involves the advancement of autologous tumor-infiltrating lymphocyte (TIL) cell therapies. Their developmental portfolio features ITIL-168, currently under investigation for a range of malignancies including melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer. Another promising candidate, ITIL-306, is engineered to identify folate receptor alpha (FOLR1) and is being explored for gynecological cancers, non-small cell lung cancer, renal cancer, and other conditions. This company was founded in 2018 and has its principal office situated in Dallas, Texas.
Over the last 12 months, insiders at Instil Bio, Inc. have bought $0 and sold $701,667 worth of Instil Bio, Inc. stock.
On average, over the past 5 years, insiders at Instil Bio, Inc. have bought $0 and sold $701,667 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 450,000 shares for transaction amount of $9M was made by Curative Ventures V LLC (10 percent owner) on 2021‑03‑23.
| 2025-09-10 | Sale | Laumas Sandeep | CFO and CBO | 30,000 0.4523% | $23.39 | $701,667 | -61.88% | |
| 2021-03-23 | Curative Ventures V LLC | 10 percent owner | 450,000 5.1249% | $20.00 | $9M | -31.22% | ||
| 2021-03-23 | Crouch Bronson | CEO and Chairman | 450,000 5.1249% | $20.00 | $9M | -31.22% | ||
| 2021-03-23 | Vivo Capital IX, LLC | 10 percent owner | 300,000 3.4166% | $20.00 | $6M | -31.22% | ||
| 2021-03-23 | Nielsen Jack | director | 300,000 3.4166% | $20.00 | $6M | -31.22% | ||
| 2021-03-23 | McGaughy R Kent Jr | director | 450,000 5.1249% | $20.00 | $9M | -31.22% | ||
| 2021-03-23 | Shah Nimish P | director | 300,000 3.4166% | $20.00 | $6M | -31.22% |
| Laumas Sandeep | CFO and CBO | 0 0% | $0 | 0 | 1 | |
| Curative Ventures V LLC | 10 percent owner | 37980073 560.0149% | $301.18M | 1 | 0 | <0.0001% |
| Crouch Bronson | CEO and Chairman | 37980073 560.0149% | $301.18M | 1 | 0 | <0.0001% |
| Nielsen Jack | director | 12486787 184.1172% | $99.02M | 1 | 0 | <0.0001% |
| Vivo Capital IX, LLC | 10 percent owner | 12486787 184.1172% | $99.02M | 1 | 0 | <0.0001% |
| McGaughy R Kent Jr | director | 8478790 125.0195% | $67.24M | 1 | 0 | <0.0001% |
| Shah Nimish P | director | 5635937 83.1017% | $44.69M | 1 | 0 | <0.0001% |
$2,542,362 | 111 | 11.81% | $52.32M | |
$155,630,608 | 79 | -24.53% | $52.39M | |
$693,326 | 47 | -16.18% | $51.71M | |
$4,898,715 | 46 | 40.75% | $58.95M | |
$48,218,096 | 42 | 0.89% | $62.14M | |
$24,478,755 | 37 | -34.59% | $57M | |
$30,257,839 | 29 | -15.72% | $56.43M | |
$226,127 | 22 | -27.62% | $50.24M | |
$17,594,514 | 16 | -20.37% | $61.45M | |
$277,862 | 15 | 59.79% | $57.18M | |
$31,610,161 | 9 | -73.83% | $52.54M | |
$106,599,960 | 6 | -7.63% | $58.13M | |
Instil Bio, Inc. (TIL) | $45,000,000 | 6 | -31.22% | $53.78M |
$208,889 | 5 | 44.22% | $46.61M | |
$762,555 | 4 | -34.52% | $59.47M | |
$67,369,250 | 3 | -22.09% | $45.44M | |
$19,175,155 | 2 | 40.00% | $61.2M | |
$150,000 | 1 | 5.48% | $51.93M | |
$4,999,995 | 1 | -67.50% | $52.26M |
| Increased Positions | 14 | +28.57% | 304,490 | +6.69% |
| Decreased Positions | 20 | -40.82% | 411,110 | -9.03% |
| New Positions | 7 | New | 201,734 | New |
| Sold Out Positions | 12 | Sold Out | 357,289 | Sold Out |
| Total Postitions | 43 | -12.24% | 4M | -2.34% |
| Curative Ventures V Llc | $21,402.00 | 27.13% | 1.9M | 0 | 0% | 2025-09-30 |
| Bml Capital Management, Llc | $7,276.00 | 9.22% | 645,600 | +110,701 | +20.7% | 2025-09-30 |
| Cpmg Inc | $4,631.00 | 5.87% | 410,922 | 0 | 0% | 2025-09-30 |
| Vivo Capital, Llc | $3,299.00 | 4.18% | 292,743 | 0 | 0% | 2025-09-30 |
| Siren, L.L.C. | $2,298.00 | 2.91% | 203,933 | 0 | 0% | 2025-09-30 |
| Millennium Management Llc | $2,217.00 | 2.81% | 196,742 | +88,645 | +82% | 2025-09-30 |
| Vanguard Group Inc | $1,891.00 | 2.4% | 167,810 | -288 | -0.17% | 2025-09-30 |
| Sectoral Asset Management Inc | $1,819.00 | 2.31% | 161,380 | +75,160 | +87.17% | 2025-09-30 |
| Morgan Stanley | $1,160.00 | 1.47% | 102,938 | +6,630 | +6.88% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $911.00 | 1.16% | 80,816 | -2,006 | -2.42% | 2025-09-30 |